SCHEMBL28552139

SCHEMBL28552139

N#C/C(=C\c1ccc(O)cc1)C(=O)N1CCNCC1

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.77
KDM4E B2RXH2 4/20 0.63
L3MBTL1 Q9Y468 2/20 0.63
EGFR P00533 3/20 0.59
KMT2A Q03164 8/20 0.56
MEN1 O00255 5/20 0.56
GAA P10253 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HPGD P15428 2/20 0.55
CISD1 Q9NZ45 1/20 0.55
SLC16A3 O15427 1/20 0.55
CYP3A4 P08684 1/20 0.55
SLC16A1 P53985 1/20 0.55
GPR35 Q9HC97 1/20 0.55
PKM P14618 1/20 0.53
ERBB2 P04626 1/20 0.49
NEK2 P51955 1/20 0.48
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28557953 0.85 EGFR (0.82) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
SCHEMBL30788166 0.85 EGFR (0.82) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
SCHEMBL28553008 0.80 EGFR (0.62) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
SCHEMBL28554525 0.77 ALDH1A1 (0.67) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
SCHEMBL3426368 0.74 ALDH1A1 (0.62) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
SCHEMBL3426371 0.74 ALDH1A1 (0.62) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
SCHEMBL14411461 0.74 EGFR (1.00) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
Hydrochloric Acid SCHEMBL3426559 0.74 ALDH1A1 (0.61) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
Hydrochloric Acid SCHEMBL3426556 0.74 ALDH1A1 (0.61) ALDH1A1KDM4EL3MBTL1EGFRKMT2A
SCHEMBL13060204 0.73 ALDH1A1 (0.74) ALDH1A1KDM4EEGFRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114656372-B P-phenylenediamine bridging compound and application thereof in preparation of medicines for treating sugar metabolism disorder diseases 广州药本君安医药科技股份有限公司 2024-06-18 CN disclosed
CN-114573476-B Linear head-tail diamine bridging compound and application thereof in preparation of medicines for treating sugar metabolic disorder diseases 广州药本君安医药科技股份有限公司 2024-06-11 CN disclosed
CN-114656371-B 1, 4-cyclohexanediamine bridged compounds and their use in the treatment of disorders of glucose metabolism 广州药本君安医药科技股份有限公司 2024-03-12 CN disclosed
CN-114656371-A 1, 4-cyclohexanediamine bridged compound and application thereof in preparing medicament for treating glycometabolism disorder diseases 广州药本君安医药科技股份有限公司 2022-06-24 CN disclosed
CN-114656372-A P-phenylenediamine bridged compound and application thereof in preparation of medicines for treating glycometabolism disorder diseases 广州药本君安医药科技股份有限公司 2022-06-24 CN disclosed
CN-114573476-A Linear head-tail diamine bridged compound and application thereof in preparing medicament for treating glycometabolism disorder diseases 广州药本君安医药科技股份有限公司 2022-06-03 CN disclosed
CN-112500314-B Compound, preparation method thereof and application thereof in preparing medicament for treating glycometabolism disorder diseases 广州药本君安医药科技股份有限公司 2022-05-13 CN disclosed
CN-112500314-A Compound, preparation method thereof and application thereof in preparing medicament for treating glycometabolism disorder diseases 广州药本君安医药科技股份有限公司 2021-03-16 CN disclosed